Title: Patent approval by US Patent and Trademark Office.

Legal basis: Article 17 (1) MAR - confidential information

Content of the Report:

The Management Board of XTPL ("Issuer", "Company", "XTPL") herebyreports that on 5 February 2024 it received the notice of allowance andinformation related to allowed claims issued by the United States Patentand Trademark Office. The patent application has been examined and isallowed for issuance as a patent for an invention "Method of filling amicrocavity with a polymer material, a filler in a microcavity, and anapparatus for filling a microcavity on or in a substrate with a polymermaterial".

The application procedure for this patent was initiated on 1 June 2021.This is also the date when patent protection started for the invention.The final formal requirement for obtaining the patent is to pay thenecessary fee. Should the requirement not be met, the Company willcommunicate this in a separate current report.

The Company's portfolio currently includes 29 patents granted.

The patent protection will increase the value of the potentialcommercialization of the Company's technology with respect to theIssuer's technological solutions for the next generation electronicsmarket. The reported event confirms continued delivery of the Company'sstrategy of building a patent cloud for its proprietary technology andproducts, which will contribute to building the Issuer's credibilityamong potential industrial clients.

In view of the above, and considering the confirmation of uniqueness ofthe Company's technological solutions, and then the outlook for theIssuer's perception by investors, the Issuer's Management Board hasdecided that the notice of allowance and information related to allowedclaims should be deemed confidential information.

For this reason, in the opinion of the Management Board, the informationmeets the criteria set out in Article 7(1) of the MAR.